• Home
  • Our Company
    • History
    • Ambition
    • Services
    • Group of companies
    • Partners
  • Quality Policy
    • Our Policy
    • Permissions & Certificates
  • Products
    • Portfolio >
      • Epinephrine Base
      • Epinephrine Bitartrate
      • Clenbuterol HCl
      • Scopolamine Base
      • Scopolamine Hydrobromide
      • Scopolamine Methylbromide
      • ... more Products
    • Portfolio TP USA
  • Team
    • Sales & Marketing
    • Logistics
    • Scientific & Regulatory
    • Administration
    • Management
    • TP USA
  • Contact
    • Germany
    • USA
    • Hong Kong
    • Singapore
  • Blog
TRANSOPHARM.COM
  • Home
  • Our Company
    • History
    • Ambition
    • Services
    • Group of companies
    • Partners
  • Quality Policy
    • Our Policy
    • Permissions & Certificates
  • Products
    • Portfolio >
      • Epinephrine Base
      • Epinephrine Bitartrate
      • Clenbuterol HCl
      • Scopolamine Base
      • Scopolamine Hydrobromide
      • Scopolamine Methylbromide
      • ... more Products
    • Portfolio TP USA
  • Team
    • Sales & Marketing
    • Logistics
    • Scientific & Regulatory
    • Administration
    • Management
    • TP USA
  • Contact
    • Germany
    • USA
    • Hong Kong
    • Singapore
  • Blog

Adrenaline base and tartrate – DMF filing in Brazil

5/6/2020

0 Comments

 
During CPhI 2019 in Frankfurt the Brazilian Health Authority, ANVISA invited stakeholders to their lecture and dialogues “APIs and the New Brazilian Regulation”.
 
The below brief summary outlines the new guidance for filling DMFs (DIFA) in Brazil as well as some API GMP issues. In respect to our Adrenaline base and tartrate we filed the CEP corresponding DMFs following the below option b) plus notification of availability of a CEP.

Picture
DMF (DIFA)
  • Brazilian abbreviation DIFA is a synonym for ASMF, DMF, AIMF
  • A new ANVISA DMF procedure will be implemented in 1st quarter 2020; only applicable for new applications; old (pending) procedures still follow the “old” procedure
  • DIFA will have the same structure and content as an EDMF; split in Applicants Part and Restricted Part
  • Accepted DIFA languages: English, Portuguese, Spanish
  • Filing per PDF; upload to ANVISA gateway max. 25 MB per file; pre-registration to the gateway (so far only in Portuguese available) is required; CD; eDIFA is under development.
  • Submission approach of the various DIFA parts as in EU: AP + RP to authorities; AP to customer
 
  • DIFA filing options:
          a) full API dossier (DIFA AP plus RP) as part of the FDF dossier
          b) DIFA procedure like an EDMF procedure in conjunction with an MAA/MAV
          c) “Expression of interest”: DIFA Submission without any MA reference; stand-alone
               review and approval

  • ANVISA didn´t tell about their review period, but deficiency letter response time will be 120 days.
  • DIFA revision procedure is analogous to CEP; very similar change classification guideline is established
  • Each API grade and/or API-polymorph needs an individual DIFA; several grades/morphs in 1 DIFA is impossible! 

GMP
  • ICH Q7 is the general framework
  • Starting material/critical intermediate justification and discussion similar to EU: When does a DMF/GMP start?
  • ANVISA´s options of GMP clearance of API manufacturers:
          a) Site was successfully inspected by a Recognized Authority
          b) Risk assessment/desk audit
          c) On-site Inspection

  • ANVISA will set up an own database containing their GMP certificates/approvals
adr_dmf_filing_brazil.pdf
File Size: 118 kb
File Type: pdf
Download File

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Categories

    All
    Alkaloids
    Cannabinoids
    CBD
    CEP
    Chief Christmas Officers
    COVID 19
    CPhI
    DCAT
    Digoxin
    EDQM
    Epinephrine
    Estriol
    GMP
    Good Bye!
    Hapila
    Little Guy
    Logistics
    Nonivamide
    Partner
    Partnership
    Phyto
    Regulation
    Regulatory
    Safety
    Season Greetings
    Supply Chain
    Transo-Pharm US


    Archives

    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    June 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    June 2020
    May 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019

    RSS Feed

Services

Sourcing
Sales
Development

Products

Portfolio
​US Portfolio

Company

History
Ambition
​Services
Group
Partners
​
Quality Policy 
​Certificates

Team

Sales & Marketing
Logistics
Scientific & Regulatory
Administration
​Management
​TP USA

Contact

Germany
Hong Kong
Singapore
USA
Sitemap
Support
German Site
Imprint / Legal
Data Privacy
Code Of Conduct
© COPYRIGHT 2020
​ALL RIGHTS RESERVED.

Picture
Picture
  • Home
  • Our Company
    • History
    • Ambition
    • Services
    • Group of companies
    • Partners
  • Quality Policy
    • Our Policy
    • Permissions & Certificates
  • Products
    • Portfolio >
      • Epinephrine Base
      • Epinephrine Bitartrate
      • Clenbuterol HCl
      • Scopolamine Base
      • Scopolamine Hydrobromide
      • Scopolamine Methylbromide
      • ... more Products
    • Portfolio TP USA
  • Team
    • Sales & Marketing
    • Logistics
    • Scientific & Regulatory
    • Administration
    • Management
    • TP USA
  • Contact
    • Germany
    • USA
    • Hong Kong
    • Singapore
  • Blog